Skincare Reviewed Jul 5, 2026

La Roche-Posay Effaclar Duo Acne Treatment

A premium "derm" benzoyl-peroxide treatment recalled for benzene in 2025.

Recall · 2025 · resolved

FDA benzoyl-peroxide benzene recall

One of six BPO products voluntarily recalled at retail in March 2025 (lot MYX46W) after FDA testing found elevated benzene. Resolved.

Source →

Our take

Why It’s on Our Radar

We don't recommend the recalled lot. A premium derm brand FDA-recalled for benzene — a cautionary listing showing the issue crosses price tiers.

What's inside

Ingredients & Safety

Benzoyl peroxide, which can degrade into benzene — the reason a specific lot was recalled.

Worth a closer look — 1 ingredient we flag:

Benzoyl Peroxide 5.5% — sometimes listed as BPO

An acne active that can chemically break down into benzene, a known carcinogen, especially when stored warm — the basis of the 2024–2025 FDA testing and recalls.

Full Ingredient List

Safe Watch Caution
  • Benzoyl Peroxide 5.5%
  • Water also listed as Aqua, Purified Water
  • Glycerin also listed as Glycerine, Vegetable Glycerin
  • Silica also listed as Silica, E551
  • Dimethicone
  • Niacinamide

Prefer a spotless pick? Three Ships in Skincare is Clean Verified — every ingredient clean, with no recalls or lawsuits on record.

Who owns it

Ownership & Independence

La Roche-Posay is owned by L'Oréal.

Where to buy

Key Products

As an Amazon Associate, we earn from qualifying purchases. Commissions never influence scores.